INPDA

A global network of non-profit organisations supporting families affected by Niemann Pick Diseases

[INPDA @inpda_org]

🥰 https://t.co/jVPMVEctLd

[INPDA @inpda_org]

https://t.co/jtbXXGL4VE

[INPDA @inpda_org]

https://t.co/DJ2LWfKgeR

[INPDA @inpda_org]

https://t.co/rI0KNHc989

[INPDA @inpda_org]

Chris Andrews, Father to Abby and Belle, two children with Niemann-Pick disease type C, shares his story with those in attendance at last month's Niemann-Pick Type C Disease Patient-Focused Drug Development Meeting.

To learn more... https://t.co/nzWRFe41cz

[INPDA @inpda_org]

We need YOUR help! ❤️

Orphazyme is working to create a new therapeutic approach to treat Niemann-Pick disease Type C. The name of the active substance... https://t.co/zeHXu7Y3Bg

[INPDA @inpda_org]

Surveys/Market Research https://t.co/FZoTZc0Mi5

[INPDA @inpda_org]

We need YOUR help! ❤️

Orphazyme is working to create a new therapeutic approach to treat Niemann-Pick disease Type C. The name of the active substance Orphazyme is investigating is called arimoclomol citrate, which is... https://t.co/mXxfBGV0aZ

[INPDA @inpda_org]

We need YOUR help! ❤️

Orphazyme is working to create a new therapeutic approach to treat Niemann-Pick disease Type C. The name of the active substance Orphazyme is investigating is called arimoclomol citrate, which is... https://t.co/mXxfBGV0aZ

[INPDA @inpda_org]

We need YOUR help! ❤️

Orphazyme is working to create a new therapeutic approach to treat Niemann-Pick disease Type C. The name of the active substance Orphazyme is investigating is called arimoclomol citrate, which is... https://t.co/mXxfBGV0aZ

[INPDA @inpda_org]

“NNPDF Industry Update Webinar Series featuring Intrabio”

INPDA International Niemann-Pick Disease Alliance member group the National Niemann-Pick Disease Foundation, Inc.'s Industry Update Webinar Series will continue on the... https://t.co/fkwy4DXkyj

[INPDA @inpda_org]

https://t.co/jTv4j0GCbH

[INPDA @inpda_org]

In the following video Helenida Tauil reports from the Associação Niemann-Pick Brasil's 1st Symposium on Rare Diseases in Londrina

For further information on INPDA International Niemann-Pick Disease Alliance member group ANPB,... https://t.co/0TvGHthcqy

[INPDA @inpda_org]

♥️ https://t.co/mU3mqQ9fIO

[INPDA @inpda_org]

🙌🏾🙌🏾🙌🏾 https://t.co/2fA2SeGswA

[INPDA @inpda_org]

https://t.co/tAWaHBSK7x

[INPDA @inpda_org]

Less than SIX months to go until INPDA founding member group Niemann-Pick UK's Annual Family Conference & Interactive Workshop on Niemann-Pick Disease(s)! https://t.co/W3Ma91EplQ

[INPDA @inpda_org]

https://t.co/VFOA4IfSVG

[INPDA @inpda_org]

Niemann-Pick Type C Externally-led Patient-Focused Drug Development Meeting (video stream now available!)

The Niemann-Pick Type C (NPC) externally led Patient-Focused Drug Development (PFDD) meeting is a groundbreaking initiative... https://t.co/G2Qk0d2MV4

[INPDA @inpda_org]

INPDA International Niemann-Pick Disease Alliance Secretary, and Niemann-Pick UK Chief Executive Toni Mathieson was honoured to be in attendance at the Niemann-Pick Type C Patient-Focused Drug Development in... https://t.co/6Qn9WnsQVx